Top Markets
#1 Black Phoenix Black Phoenix +167.53%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.49%
#5 Test Test +23.70%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.98%
#9 Steem Steem +13.65%
#10 MarsCoin MarsCoin +9.72%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
Classifica tra le azioni #41547
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
Prezzo delle azioni
$0.00196068
Ultima sincronizzazione: 2023-12-01
Capitalizzazione di mercato
$16.64K
Variazione (1 giorno)
0.01%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Genomic Vision S.A. (GV)

Categoria

Healthcare
Il prezzo GV con la capitalizzazione del mercato della B
Genomic Vision S.A. Genomic Vision S.A.
GV
$0.00196068
Capitalizzazione di mercato di Genomic Vision S.A.(GV)
Capitalizzazione di mercato: $16.64K
A partire dal August 2026, Genomic Vision S.A. ha una capitalizzazione di mercato pari a $16.64K. Questo rende Genomic Vision S.A. la 41547th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Genomic Vision S.A. dal 2014 al 2026
GV in paragone con la classifica dei più popolari stocks
Il prezzo per GV Attivo B Capitalizzazione del mercato a B Risultati
Genomic Vision S.A. Genomic Vision S.A.
$634,318 $16.64K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,352,000,318.50%
Genomic Vision S.A. Genomic Vision S.A.
$521,206 $16.64K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,582,945,946.58%
Genomic Vision S.A. Genomic Vision S.A.
$490,214 $16.64K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +25,002,282,125.49%
Genomic Vision S.A. Genomic Vision S.A.
$431,647 $16.64K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +22,015,203,999.28%
Genomic Vision S.A. Genomic Vision S.A.
$340,672 $16.64K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,375,216,229.83%